[Component therapy with cryo-poor plasma (CPP)].
National blood programs are means of strategy in the hands of the transfusiologists. Because of the dramatically increase of FFP use new ways in component therapy have to be gone. The use of CPP instead of FFP in operative medicine is one possibility to support an increasing demand of factor VIII. The first results of a clinical trial with special attention to factors I and VIII are presented in this article.
Roewer
J
J
Bezirksinstitut für Blutspende- und Transfusionswesen Rostock, DDR.
Dettmann
C
C
D001781:Blood Component Removal / Q000379:methods*; D001803:Blood Transfusion / Q000379:methods*; D017707:Erythrocyte Transfusion; D005169:Factor VIII / Q000008:administration & dosage*; D005340:Fibrinogen / Q000008:administration & dosage; D006801:Humans; D010949:Plasma
D005169:Factor VIII; D005340:Fibrinogen
Komponententherapie mit Cryo-Poor-Plasma (CPP).